HCA Healthcare (HCA) Wells Fargo 21st Annual Healthcare Conference summary

Demand environment and market trends

• Demand for healthcare in Southeast and Southwest regions is expected to grow 2%-3% annually, driven by population migration and vibrant local economies.

• 99% of business performed as expected or better, despite negative policy impacts from the expiration of enhanced premium tax credits.

• Commercial volumes rebounded in Q2, with continued optimism for employer-based coverage and job growth.

• Competitive dynamics remain strong, but market share is growing modestly due to network strategy and analytics.

• Medicaid expansion and related policies are manageable, with most exposure in non-expansion states.

Strategic initiatives and organizational changes

• Creation of the Ambulatory Operations Group to coordinate and grow a network of 3,000+ outpatient facilities.

• Promotion of Dr. Michael Schlosser to Chief Clinical Officer to integrate digital and clinical teams for innovation.

• Acquisition of The College of Health Care Professions to address allied health workforce needs and complement nursing education expansion.

• Enterprise initiatives focus on connecting local and national systems, leveraging scale, and enhancing efficiency.

• Investments in digital transformation, including MEDITECH Expanse rollout and AI-driven clinical tools.

Financial performance and guidance

• Core business is performing near the high end of long-term EBITDA growth guidance (4%-6%), despite a 3% downward revision in core guidance due to exchange-related headwinds.

• Surgical volume declines are mainly attributed to exchange (HIX) population changes, with minor impacts from consumer sentiment and Medicare rule changes.

• Labor costs are managed through operational leverage, overhead reduction, and benchmarking, resulting in SWB per adjusted admission down 1% year-over-year.

• Resiliency programs are expected to have a greater positive impact in Q4, aided by easier year-over-year comparisons.

• Collection rates for higher deductibles and co-pays remain stable, with pressure points factored into guidance.